Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...

Toxidromes: Clinical Features

Toxidromes: Clinical Features

Toxidromes are specific patterns of symptoms resulting from toxic substance exposure. They help in the identification and treatment of poisoning. The symptoms of each toxidrome group indicate poisoning by a certain class of chemicals or drugs.1. Sympathomimetic: Stimulates the sympathetic nervous system. Symptoms include agitation, increased heart rate (HR), blood pressure (BP), respiratory rate (RR), temperature, and pupil size. Drugs like cocaine and amphetamines, along with tremors and...

Indirect-Acting Cholinergic Agonists: Pharmacokinetics

Indirect-Acting Cholinergic Agonists: Pharmacokinetics

Indirect-acting cholinergic agonists, or anticholinesterases, enhance the body's cholinergic activity by inhibiting acetylcholine's breakdown. They are categorized as reversible or irreversible agents based on their mechanism of action. They are further classified into short-acting, intermediate-acting, and long-acting agents based on their duration of action.
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they are...

Pharmaceutical Poisoning: Treatment Strategies

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...

Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...

Botulism

Botulism

Botulism is a life-threatening neuroparalytic condition caused by botulinum neurotoxin, which is produced by the bacterium Clostridium botulinum, a Gram-positive, spore-forming, obligate anaerobe.In adults, the toxin enters the body in different ways: in foodborne botulism, the preformed toxin is absorbed in the intestine. In wound botulism, spores grow in injured tissue and release the toxin into the blood. Infant botulism differs mechanistically from adult forms. In infants, botulism commonly...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Clinical profile of patients with systemic lupus erythematosus.

JNMA; journal of the Nepal Medical Association·2013

Same author

Eosinophilic fascitis: a rare fibrosing disorder.

Kathmandu University medical journal (KUMJ)·2013

Same author

A diagnosis missed for several years-Wegener's granulomatosis.

Kathmandu University medical journal (KUMJ)·2012

Same author

Lemierre's syndrome in a patient with severe lupus nephritis.

JNMA; journal of the Nepal Medical Association·2012

Same author

Bone and joint decade 2000-2010 in Nepalese perspective.

JNMA; journal of the Nepal Medical Association·2011

Same author

Hemidiaphragmatic paralysis: a rare complication of cervical herpes zoster.

Kathmandu University medical journal (KUMJ)·2008

Search research articles

Related Experiment Video

Updated: Jun 27, 2026

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Published on: January 7, 2014

Organophosphorus poisoning.

¹Department of Medicine, Patan Hospital, Lalitpur. buddhipaudyal@yahoo.com

JNMA; Journal of the Nepal Medical Association

|December 17, 2008

Summary

This summary is machine-generated.

Organophosphorus (OP) pesticide poisoning is a significant global health issue. Research is urgently needed to address unanswered questions and controversies in managing OP poisoning, improving patient outcomes.

More Related Videos

Oral Administration of Rotenone using a Gavage and Image Analysis of Alpha-synuclein Inclusions in the Enteric Nervous System

Oral Administration of Rotenone using a Gavage and Image Analysis of Alpha-synuclein Inclusions in the Enteric Nervous System

Published on: October 26, 2010

Related Experiment Videos

Last Updated: Jun 27, 2026

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Published on: January 7, 2014

Oral Administration of Rotenone using a Gavage and Image Analysis of Alpha-synuclein Inclusions in the Enteric Nervous System

Oral Administration of Rotenone using a Gavage and Image Analysis of Alpha-synuclein Inclusions in the Enteric Nervous System

Published on: October 26, 2010

Area of Science:

Toxicology
Clinical Medicine
Environmental Health

Background:

Acute organophosphorus (OP) poisoning is a major global clinical problem, particularly in developing countries.
Commonly ingested OP pesticides include Metacid (Methyl parathion) and Nuvan (Dichlorovos).
OP toxicity results from irreversible acetylcholinesterase (AChE) inhibition, leading to cholinergic crisis, intermediate syndrome, and delayed polyneuropathy.

Purpose of the Study:

To review the current understanding of organophosphorus (OP) poisoning.
To highlight the diagnostic and therapeutic challenges in managing OP poisoning.
To emphasize the need for further research in OP poisoning management.

Main Methods:

Review of clinical presentation and diagnosis of OP poisoning.
Discussion of supportive treatments including airway, breathing, and circulation management.
Analysis of decontamination procedures (gastric lavage, activated charcoal) and therapeutic agents (atropine, cholinesterase reactivators).

Main Results:

Diagnosis relies on exposure history, characteristic toxicity, and response to atropine.
Atropine is crucial for managing life-threatening features, but optimal dosing and duration lack clear guidelines.
Cholinesterase reactivators show potential but have inconsistent clinical trial results.

Conclusions:

There are significant unanswered questions and controversies in the clinical management of OP poisoning.
Further research is urgently required to establish clear guidelines for OP poisoning treatment.
Improved management strategies are needed for this common and deadly poisoning.